Gene Therapy - 2/7

Entry	Author	Date	Location
Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details	Luke Timmerman	04/28/10	San Diego
Sensata and Aveo Go Public; Genetix, Rhythm, and CorrelSense Get Funding; Pegasystems to Acquire Chordiant; & More Boston-Area Deals News	Erin Kutz	03/17/10	Boston
Genetix Pharma Raises $35M from Third Rock, Genzyme for Gene Therapy	Ryan McBride	03/12/10	Boston
West Wireless Names CEO, Amylin Pharmaceuticals Awaits FDA Deadline, Life Technologies In Cancer Research Partnership, & More San Diego Life Sciences News	Denise Gellene	03/11/10	San Diego
Tocagen, Developing Anti-Cancer Therapies, Close to Closing on $8M Round	Bruce V. Bigelow	03/08/10	San Diego
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News	Luke Timmerman	01/14/10	Seattle
Targeted Genetics Exits Nasdaq	Luke Timmerman	01/13/10	Seattle
Kala Pharmaceuticals, Stealthy New Company Tied to MIT’s Bob Langer, Gets $2M	Luke Timmerman	12/23/09	Boston
New Life Sciences Startup Shows UCSD Technology Can Boost Immune Response to Cancer in Mice	Bruce V. Bigelow	10/14/09	San Diego
Celladon, Developer of Gene Therapy for Heart Failure, Secures Part of $24.6M Venture Round	Luke Timmerman	09/15/09	San Diego
Arena Prepares to Release Big Obesity Study, Minnow Medical Goes Into ‘Commercialization Mode,’ Metabasis Hires Strategic Adviser, & More San Diego Life Sciences News	Bruce V. Bigelow	09/10/09	San Diego
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News	Luke Timmerman	09/10/09	Seattle
Targeted Genetics Survives Brush With Death, Sells Gene Therapy IP to Genzyme for $7M	Luke Timmerman	09/09/09	National
AVI Offers Glimmer of Hope for Muscular Dystrophy, Says UW Neuroscientist Jeff Chamberlain	Luke Timmerman	09/01/09	Seattle
Targeted Genetics’ Legacy: No Cures, But a Generation of Seattle Biotechies	Luke Timmerman	08/25/09	Seattle
Why Big Pharma Wants To Be Like Big Biotech	Stewart Lyman	08/19/09	National
Targeted ‘Must Raise’ Cash	Luke Timmerman	08/12/09	Seattle
Targeted Genetics Amends Lease	Luke Timmerman	07/24/09	Seattle
Targeted Genetics Dumps Lease, Amgen’s Dmab Works in Cancer Trial, Theraclone Nabs Cash, & More Seattle-Area Life Sciences News	Luke Timmerman	07/09/09	Seattle
Targeted Genetics Sheds Lease	Luke Timmerman	07/06/09	Seattle
Targeted Genetics Cuts Workforce in Half in Bid to Survive Into August	Luke Timmerman	06/22/09	Seattle
Amylin Dissidents Win Board Seats, Targeted Genetics’ Troubles Raise Gene Therapy Concerns, Celladon Eyes Partnership, & More San Diego Life Sciences News	Bruce V. Bigelow	06/04/09	San Diego
Experimental Gene Therapy for Blindness Will Proceed Even if Targeted Genetics Goes Dark	Denise Gellene	06/03/09	San Diego
Celladon CEO Upbeat on Gene Therapy for Heart	Denise Gellene	05/29/09	San Diego
David M. Bodine Q&A: Making Progress on Gene Therapy, Despite Targeted Genetics’ Woes	Denise Gellene	05/27/09	San Diego
Targeted Genetics, Mainstay of Gene Therapy, Faces Likely Shutdown	Luke Timmerman	05/07/09	Seattle
Genzyme Enters Seattle Hub, Oncothyreon Bets on Cancer Drugs, Pathway Nabs $40M, & More Seattle-Area Life Sciences News	Luke Timmerman	04/02/09	Seattle
Targeted Ends Year With $5.2M	Luke Timmerman	03/31/09	Seattle
Genzyme Gene Therapy Fails To Help People with Leg Disease Walk Longer	Luke Timmerman	03/31/09	Boston
Sticking to its Guns with Gene Therapy, Genzyme To Present Key Findings Within Days	Luke Timmerman	03/25/09	Boston
Page 2 of 3	« previous page · next page »

Entry

Author

Date

Location

Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details

04/28/10

Sensata and Aveo Go Public; Genetix, Rhythm, and CorrelSense Get Funding; Pegasystems to Acquire Chordiant; & More Boston-Area Deals News

Erin Kutz

03/17/10

Boston

Genetix Pharma Raises $35M from Third Rock, Genzyme for Gene Therapy

Ryan McBride